Haemolytic uraemic syndrome during FK506 therapy. 1992

T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno

UI MeSH Term Description Entries
D005260 Female Females
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting
D016559 Tacrolimus A macrolide isolated from the culture broth of a strain of Streptomyces tsukubaensis that has strong immunosuppressive activity in vivo and prevents the activation of T-lymphocytes in response to antigenic or mitogenic stimulation in vitro. Anhydrous Tacrolimus,FK-506,FK506,FR-900506,Prograf,Prograft,Tacrolimus Anhydrous,Anhydrous, Tacrolimus,FK 506,FR 900506,FR900506,Tacrolimus, Anhydrous

Related Publications

T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
January 1989, Lancet (London, England),
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
July 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene,
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
December 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
September 1969, Lancet (London, England),
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
January 1970, Lancet (London, England),
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
July 1974, British medical journal,
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
February 2017, Journal of internal medicine,
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
January 2011, Nephron. Clinical practice,
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
November 1968, Lancet (London, England),
T Ichihashi, and T Naoe, and H Yoshida, and H Kiyoi, and H Fukutani, and K Kubo, and T Yamauchi, and H Saito, and R Ohno
November 1984, Lancet (London, England),
Copied contents to your clipboard!